Literature DB >> 8564359

BCG vaccination against tuberculosis: past disappointments and future hopes.

P W Roche1, J A Triccas, N Winter.   

Abstract

Three billion doses of the bacille Calmette-Guérin (BCG) vaccine have been given over the past 60 years. BCG has a widely variable ability to protect humans against tuberculosis. This article examines some of the reasons for this variability, and discusses ways in which BCG vaccination might be improved.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8564359     DOI： 10.1016/s0966-842x(00)88986-6

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  22 in total

1.  Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille calmette-Guérin (BCG).

Authors:  G Batoni; S Esin; M Pardini; D Bottai; S Senesi; H Wigzell; M Campa
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  Elements of signal transduction in Mycobacterium tuberculosis: in vitro phosphorylation and in vivo expression of the response regulator MtrA.

Authors:  L E Via; R Curcic; M H Mudd; S Dhandayuthapani; R J Ulmer; V Deretic
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

3.  Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes.

Authors:  J Hess; D Miko; A Catic; V Lehmensiek; D G Russell; S H Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

4.  Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis.

Authors:  S L Baldwin; C D'Souza; A D Roberts; B P Kelly; A A Frank; M A Lui; J B Ulmer; K Huygen; D M McMurray; I M Orme
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 5.  Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.

Authors:  Rosamund Chapman; Gerald Chege; Enid Shephard; Helen Stutz; Anna-Lise Williamson
Journal:  Curr HIV Res       Date:  2010-06       Impact factor: 1.581

6.  Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model.

Authors:  Heidi A Schreiber; Paul D Hulseberg; JangEun Lee; Jozsef Prechl; Peter Barta; Nora Szlavik; Jeffrey S Harding; Zsuzsanna Fabry; Matyas Sandor
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

7.  Interleukin-15 as an immune adjuvant to increase the efficacy of Mycobacterium bovis bacillus Calmette-Guérin vaccination.

Authors:  Masayuki Umemura; Hitoshi Nishimura; Kimika Saito; Toshiki Yajima; Goro Matsuzaki; Satoru Mizuno; Isamu Sugawara; Yasunobu Yoshikai
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Lung macrophages from bacille Calmette-Guérin-vaccinated guinea pigs suppress T cell proliferation but restrict intracellular growth of M. tuberculosis after recombinant guinea pig interferon-gamma activation.

Authors:  A Jeevan; K Majorov; K Sawant; H Cho; D N McMurray
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

9.  Expression of interferon-gamma and tumour necrosis factor-alpha messenger RNA does not correlate with protection in guinea pigs challenged with virulent Mycobacterium tuberculosis by the respiratory route.

Authors:  Amminikutty Jeevan; Diana Lucia Bonilla; David Neil McMurray
Journal:  Immunology       Date:  2008-11-07       Impact factor: 7.397

Review 10.  Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.

Authors:  F Abebe
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.